Medizinische Universität Graz - Research portal

Go directly to the nagivation.
Go directly to the content.

Navigation/Search

Researchers.
- Curriculum.
- Publications.
- Projects.
- Presentations.
Institutions.
Projects.
Publications.
Partners.
Sponsors.
Equipment.
Knowhow.
Fields of Research.

Höller Viktoria |

Publications

** = Publications listed in SCI/SSCI/Pubmed

2025

Full paper/article (Journal)

** Cejka, V; Riepl, H; Schwegel, N; Kolesnik, E; Zach, D; Santner, V; Höller, V; Schweighofer, N; Obermayer-Pietsch, B; Pieber, T; Morbach, C; Frantz, S; Zirlik, A; von, Lewinski, D; Störk, S; Posch, F; Ablasser, K; Verheyen, N Prognostic impact of gait speed, muscle strength and muscle mass in chronic heart failure-A prospective cohort study.
ESC Heart Fail. 2025; 12(3):2113-2124 Doi: 10.1002/ehf2.15221 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

Case Report

** Höller, V; Santner, V; Schmid, J; Zirlik, A; Verheyen, N Variant cardiac transthyretin amyloidosis presenting as hypertrophic cardiomyopathy with left ventricular outflow tract obstruction: a case report
EUR HEART J-CASE REP. 2025; 9(2): ytaf029 Doi: 10.1093/ehjcr/ytaf029 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

2024

Full paper/article (Journal)

** Schwegel, N; Toferer, C; Zach, DK; Santner, V; Höller, V; Lugitsch, J; Wallner, M; Gollmer, J; Aziz, F; von, Lewinski, D; Kolesnik, E; Ablasser, K; Zirlik, A; Sourij, H; Verheyen, N Impact of SGLT2-Inhibitor Therapy on Survival in Patients with Transthyretin Amyloid Cardiomyopathy: Analysis of a Prospective Registry Study.
J Clin Med. 2024; 13(19): Doi: 10.3390/jcm13195966 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

** Schwegel, N; Zach, D; Peikert, A; Santner, V; Höller, V; Gollmer, J; Späth, J; Riepl, H; Rainer, PP; Wallner, M; Pilz, S; Zirlik, A; von, Lewinski, D; Ablasser, K; Verheyen, N; Kolesnik, E The Prognostic Value of Right Ventricular Function in Patients with Chronic Heart Failure-A Prospective Study.
J Clin Med. 2024; 13(7): 1930 Doi: 10.3390/jcm13071930 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

** Verheyen, N; Schmid, J; Kolesnik, E; Schwegel, N; Späth, J; Kattnig, L; Riepl, H; Zach, D; Santner, V; Höller, V; Pilz, S; Tomaschitz, A; Fuchsjäger, M; Fahrleitner-Pammer, A; Dimai, HP; Obermayer-Pietsch, B; Fruhwald, F; Scherr, D; Zirlik, A; von, Lewinski, D; Ablasser, K Prevalence and prognostic impact of bone disease in chronic heart failure with reduced ejection fraction.
ESC Heart Fail. 2024; 11(3):1730-1738 Doi: 10.1002/ehf2.14741 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

** Zach, DK; Schwegel, N; Santner, V; Winkelbauer, L; Hoeller, V; Kolesnik, E; Gollmer, J; Seggewiss, H; Batzner, A; Perl, S; Wallner, M; Reiter, U; Rainer, PP; Zirlik, A; Ablasser, K; Verheyen, N Low-grade systemic inflammation and left ventricular dysfunction in hypertensive compared to non-hypertensive hypertrophic cardiomyopathy.
Int J Cardiol. 2024; 399:131661 Doi: 10.1016/j.ijcard.2023.131661
Web of Science PubMed FullText FullText_MUG

Abstract (Journal)

** Ungericht, M; Messner, M; Puelacher, C; Schuetz, T; Staggl, S; Zaruba, MM; Willenbacher, W; Weger, R; Rittler, S; Agis, H; Krauth, MT; Weber, T; Höller, V; Verheyen, N; Ebner, C; Strassl, I; Pichler, P; Darling, P; Pölzl, G Prevalence and outcome of coronary artery disease in cardiac amyloidosis: a retrospective Austrian multicenter study
AMYLOID. 2024; 31: S147-S147. [Poster]
Web of Science

2023

Full paper/article (Journal)

** Santner, V; Riepl, HS; Posch, F; Wallner, M; Rainer, PP; Ablasser, K; Kolesnik, E; Hoeller, V; Zach, D; Schwegel, N; Kreuzer, P; Lueger, A; Petutschnigg, J; Pieske, B; Zirlik, A; Edelmann, F; Verheyen, N Non-eligibility for pivotal HFpEF/HFmrEF outcome trials and mortality in a contemporary heart failure cohort.
Eur J Intern Med. 2023; 118:73-81 Doi: 10.1016/j.ejim.2023.07.027
Web of Science PubMed FullText FullText_MUG

Abstract (Journal)

** Lugitsch, J; Hoeller, V; Schwegel, N; Santner, V; Gollmer, J; Kolesnik, E; Lipp, R; Niedrist, T; Rainer, P; Zirlik, A; Ablasser, K; Verheyen, N; Zach, D Interleukin-6 plasma levels predict mortality and heart failure events in cardiac transthyretin amyloidosis
EUR HEART J. 2023; 44: -Annual Meeting of the European-Society-of-Cardiology (ESC); AUG 25-28, 2023; Amsterdam, NETHERLANDS. [Poster]
Web of Science

** Lugitsch, J; Holler, V; Schwegel, N; Santner, V; Gollmer, J; Kolesnik, E; Lipp, R; Niedrist, T; Rainer, P; Zirlik, A; Ablasser, K; Verheyen, N; Zach, D Interleukin-6 plasma levels predict mortality and heart failure events in cardiac transthyretin amyloidosis
WIEN KLIN WOCHENSCHR. 2023; 135: S472-S473. [Poster]
Web of Science FullText

** Schwegel, N; Riepl, H; Spath, J; Kolesnik, E; Zach, D; Santner, V; Holler, V; Obermayer-Pietsch, B; Schmid, J; Scherr, D; von Lewinski, D; Zirlik, A; Ablasser, K; Verheyen, N Role of Comorbidities in Chronic Heart Failure-a prospective cohort study
WIEN KLIN WOCHENSCHR. 2023; 135: S477-S477.
Web of Science FullText

** Willenbacher, W; Agis, H; Krauth, MT; Rodriguez-Torres, C; Strassl, I; Verheyen, ND; Hoeller, V; Darling, P; Pichler, P; Rittler, S; Weger, R; Willenbacher, E Real-World Outcomes and Treatment Patterns in AL-Amyloidosis in Austria: An Analysis from the Austrian Interdisciplinary Amyloidosis Registry (AIDA)
BLOOD. 2023; 142: Doi: 10.1182/blood-2023-187598
Web of Science FullText FullText_MUG

** Zach, D; Schwegel, N; Hoeller, V; Kolesnik, E; Gollmer, J; Reiter, U; Seggewiss, H; Batzner, A; Zirlik, A; Rainer, P; Ablasser, K; Verheyen, N Comparing indices of systemic inflammation and cardiac phenotype between hypertensive and non-hypertensive hypertrophic cardiomyopathy
EUR HEART J. 2023; 44: -Annual Meeting of the European-Society-of-Cardiology (ESC); AUG 25-28, 2023; Amsterdam, NETHERLANDS. [Poster]
Web of Science

** Zach, D; Schwegel, N; Holler, V; Kolesnik, E; Gollmer, J; Reiter, U; Seggewiss, H; Batzner, A; Zirlik, A; Rainer, P; Ablasser, K; Verheyen, N Comparing indices of systemic inflammation and cardiac phenotype in hypertensive and non-hypertensive hypertrophic cardiomyopathy
WIEN KLIN WOCHENSCHR. 2023; 135: S475-S476. [Poster]
Web of Science FullText

2022

Full paper/article (Journal)

** Verheyen, N; Ungericht, M; Paar, L; Danninger, K; Schneiderbauer-Porod, S; Duca, F; Cherouny, B; Hoeller, V; Ablasser, K; Zach, D; Kolesnik, E; Kiblboeck, D; Frick, M; Bonderman, D; Dierneder, J; Ebner, C; Weber, T; Pölzl, G Diagnostic Accuracy of Bone Scintigraphy for the Histopathological Diagnosis of Cardiac Transthyretin Amyloidosis-A Retrospective Austrian Multicenter Study.
Biomedicines. 2022; 10(12): Doi: 10.3390/biomedicines10123052 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

Abstract (Journal)

** Grubler, M; Zach, D; Holler, V; Seebacher, HA; Verheyen, N A rare genetic cause of left ventricular hypertrophy and heart failure with preserved ejection fraction
WIEN KLIN WOCHENSCHR. 2022; 134(SUPPL 2):129-129. [Poster]
Web of Science

** Verheyen, N; Ungericht, M; Paar, L; Danninger, K; Schneiderbauer-Porod, S; Duca, F; Cherouney, B; Holler, V; Ablasser, K; Zach, D; Kiblbock, D; Frick, M; Bonderman, D; Dierneder, J; Ebner, C; Weber, T; Polzl, G Diagnostic accuracy of amyloid scintigraphy for the histopathological diagnosis of cardiac transthyretin amyloidosis-a retrospective Austrian multicenter study
WIEN KLIN WOCHENSCHR. 2022; 134(SUPPL 2): 89-90. [Poster]
Web of Science

** Verheyen, N; Ungericht, M; Paar, L; Danninger, K; Schneiderbauer-Porod, S; Duca, F; Hoeller, V; Ablasser, K; Kiblboeck, D; Frick, M; Bonderman, D; Dierneder, J; Ebner, C; Weber, T; Poelzl, G Diagnostic accuracy of amyloid scintigraphy for the histopathological diagnosis of cardiac transthyretin amyloidosis - a retrospective Austrian multicenter study
EUR HEART J. 2022; 43: 903-903.
Web of Science

2021

Full paper/article (Journal)

** Höller, V; Seebacher, H; Zach, D; Schwegel, N; Ablasser, K; Kolesnik, E; Gollmer, J; Waltl, G; Rainer, PP; Verheyen, S; Zirlik, A; Verheyen, N Myocardial Deformation Analysis in MYBPC3 and MYH7 Related Sarcomeric Hypertrophic Cardiomyopathy-The Graz Hypertrophic Cardiomyopathy Registry.
Genes (Basel). 2021; 12(10): Doi: 10.3390/genes12101469 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

Case Report

** Zach, D; Ablasser, K; Kolesnik, E; Hoeller, V; Fruhwald, F; Prüller, F; Reiter, C; Beham-Schmid, C; Lipp, R; Rainer, PP; Zirlik, A; Wölfler, A; Verheyen, N Advanced isolated light chain amyloid cardiomyopathy with negative immunofixation and normal free light chain ratio.
ESC Heart Fail. 2021; 8(4):3397-3402 Doi: 10.1002/ehf2.13381 (- Case Report) [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

Abstract (Journal)

** Holler, V; Zach, D; Kolesnik, E; Wallner, M; Fruhwald, F; Rainer, P; Zirlik, A; Verheyen, N Proportions and temporal trends of diseases leading to a hypertrophic cardiomyopathy phenotype. a prospective single-center cohort study
WIEN KLIN WOCHENSCHR. 2021; 133(SUPPL 3):S98-S98. [Onlinepräsentation]
Web of Science

↑ Top of page / Navigation